Literature DB >> 11248710

The role of exon 5 in fibroblast collagenase (MMP-1) substrate specificity and inhibitor selectivity.

V Knäuper1, M L Patterson, F X Gomis-Rüth, B Smith, A Lyons, A J Docherty, G Murphy.   

Abstract

Interstitial collagen is degraded by members of the matrix metalloproteinase (MMP) family, including MMP-1. Previous work has shown that the region of MMP-1 coded for by exon 5 is implicated both in substrate specificity and inhibitor selectivity. We have constructed a chimeric enzyme, the exon 5 chimera, consisting primarily of MMP-1, with the region coded for by exon 5 replaced with the equivalent region of MMP-3, a noncollagenolytic MMP. Unlike MMP-3, the exon 5 chimera is capable of cleaving type I collagen, but the activity is only 2.2% of trypsin-activated MMP-1. 'Superactivation' of the chimera has no discernible effect, suggesting that the salt bridge formed in 'superactive' MMP-1 is not present. The kinetics for exon 5 chimera cleavage of two synthetic substrates display an MMP-3 phenotype, however, cleavage of gelatin is slightly impaired as compared to the parent enzymes. The K(iapp) values for the exon 5 chimera complexed with synthetic inhibitors and N-terminal TIMP-2 also show a more MMP-3-like behaviour. However, the k(on) values for N-terminal TIMP-1 and N-terminal TIMP-2 are more comparable to those for MMP-1. These data show that the region of MMP-1 coded for by exon 5 is involved in both substrate specificity and inhibitor selectivity and the structural basis for our findings is discussed.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11248710

Source DB:  PubMed          Journal:  Eur J Biochem        ISSN: 0014-2956


  5 in total

Review 1.  Interstitial collagen catabolism.

Authors:  Gregg B Fields
Journal:  J Biol Chem       Date:  2013-02-19       Impact factor: 5.157

2.  The interface between catalytic and hemopexin domains in matrix metalloproteinase-1 conceals a collagen binding exosite.

Authors:  Laurence H Arnold; Louise E Butt; Stephen H Prior; Christopher M Read; Gregg B Fields; Andrew R Pickford
Journal:  J Biol Chem       Date:  2011-10-26       Impact factor: 5.157

3.  Identification of specific hemopexin-like domain residues that facilitate matrix metalloproteinase collagenolytic activity.

Authors:  Janelle L Lauer-Fields; Michael J Chalmers; Scott A Busby; Dmitriy Minond; Patrick R Griffin; Gregg B Fields
Journal:  J Biol Chem       Date:  2009-07-01       Impact factor: 5.157

4.  Alterations in the chondrocyte surfaceome in response to pro-inflammatory cytokines.

Authors:  Bernadette Jeremiasse; Csaba Matta; Christopher R Fellows; David J Boocock; Julia R Smith; Susan Liddell; Floris Lafeber; Willem E van Spil; Ali Mobasheri
Journal:  BMC Mol Cell Biol       Date:  2020-06-26

Review 5.  Matrix metalloproteinases in arthritic disease.

Authors:  Gillian Murphy; Vera Knäuper; Susan Atkinson; George Butler; William English; Mike Hutton; Jan Stracke; Ian Clark
Journal:  Arthritis Res       Date:  2002-05-09
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.